Director/PDMR Shareholding

RNS Number : 2110A

GlaxoSmithKline PLC

27 January 2011

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Due to an administrative error the details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc, were incorrectly stated in the announcement made on 5 January 2011. The correct details are set out below:

On 31 December 2010, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2010:

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment

Non-Executive Director	No. of Ordinary Shares	Average Price (£)	No. of ADSs	Average Price ($)
Sir Christopher Gent	2,708.77	12.55
Prof Sir Roy Anderson	304.57	12.55
Dr Stephanie Burns			272.27	39.18
Mr Lawrence Culp			975.65	39.18
Sir Crispin Davis	2,206.00	12.55
Sir Deryck Maughan			866.69	39.18
Mr James Murdoch	131. 50	12.55
Dr Daniel Podolsky			435.93	39.18
Mr Tom de Swaan	471.19	12.55
Sir Robert Wilson	622.79	12.55

The Company and the Non-Executive Directors were informed of these allocations on 27 January 2011.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

27 January 2011

 

END

 

 

RDSZDLFLFFFZBBQ